Histological assessment of nonalcoholic fatty liver disease in adults and children.
作者信息
Brunt Elizabeth M
机构信息
Department of Pathology and Immunology Washington University School of Medicine St. Louis MO.
出版信息
Clin Liver Dis (Hoboken). 2012 Sep 25;1(4):108-111. doi: 10.1002/cld.31. eCollection 2012 Sep.
Abstract
摘要
相似文献
1
Histological assessment of nonalcoholic fatty liver disease in adults and children.
Clin Liver Dis (Hoboken). 2012 Sep 25;1(4):108-111. doi: 10.1002/cld.31. eCollection 2012 Sep.
2
Nonalcoholic fatty liver disease in the pediatric population: a review.
Curr Opin Pediatr. 2005 Oct;17(5):636-41. doi: 10.1097/01.mop.0000172816.79637.c5.
3
Fatty liver and the metabolic syndrome.
Curr Opin Gastroenterol. 2007 Mar;23(2):193-8. doi: 10.1097/MOG.0b013e32801421a9.
4
Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
Eur J Gastroenterol Hepatol. 2010 Jun;22(6):643-50. doi: 10.1097/MEG.0b013e32832ca0cb.
5
Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease.
Semin Liver Dis. 2008 Nov;28(4):380-5. doi: 10.1055/s-0028-1091982. Epub 2008 Oct 27.
6
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients.
Oxid Med Cell Longev. 2019 Oct 15;2019:8742075. doi: 10.1155/2019/8742075. eCollection 2019.
7
Evaluation of nonalcoholic fatty liver disease using magnetic resonance in obese children and adolescents.
J Pediatr (Rio J). 2019 Jan-Feb;95(1):34-40. doi: 10.1016/j.jped.2017.12.010. Epub 2018 Feb 10.
8
Nonalcoholic fatty liver disease (NAFLD) pathophysiology in obese children and adolescents: update.
Nutr Hosp. 2017 Jun 5;34(3):727-730. doi: 10.20960/nh.723.
9
Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Metabolism. 2016 Aug;65(8):1080-6. doi: 10.1016/j.metabol.2015.11.008. Epub 2015 Dec 2.
10
Hyperinsulinemia and the development of nonalcoholic Fatty liver disease in nondiabetic adults.
Am J Med. 2011 Jan;124(1):69-76. doi: 10.1016/j.amjmed.2010.08.012.
引用本文的文献
1
Neutrophil extracellular traps promote MASH fibrosis by metabolic reprogramming of HSC.
Hepatology. 2025 Mar 1;81(3):947-961. doi: 10.1097/HEP.0000000000000762. Epub 2024 Jan 24.
2
Fumigaclavine C ameliorates liver steatosis by attenuating hepatic de novo lipogenesis via modulation of the RhoA/ROCK signaling pathway.
BMC Complement Med Ther. 2023 Aug 16;23(1):288. doi: 10.1186/s12906-023-04110-9.
3
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD).
J Clin Exp Hepatol. 2023 Mar-Apr;13(2):273-302. doi: 10.1016/j.jceh.2022.11.014. Epub 2022 Dec 7.
4
The role of the tryptophan-NAD + pathway in a mouse model of severe malnutrition induced liver dysfunction.
Nat Commun. 2022 Dec 8;13(1):7576. doi: 10.1038/s41467-022-35317-y.
5
The Human TOR Signaling Regulator Is the Key Indicator of Liver Cancer Patients' Overall Survival: TIPRL/LC3/CD133/CD44 as Potential Biomarkers for Early Liver Cancers.
Cancers (Basel). 2021 Jun 11;13(12):2925. doi: 10.3390/cancers13122925.
6
From the origin of NASH to the future of metabolic fatty liver disease.
Gut. 2021 Feb 25;70(8):1570-9. doi: 10.1136/gutjnl-2020-323202.
7
DNA Methylation in Nonalcoholic Fatty Liver Disease.
Int J Mol Sci. 2020 Oct 30;21(21):8138. doi: 10.3390/ijms21218138.
8
Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets for Therapeutics.
Front Immunol. 2020 Oct 8;11:2013. doi: 10.3389/fimmu.2020.02013. eCollection 2020.
9
Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223.
J Clin Invest. 2019 Jul 11;129(10):4091-4109. doi: 10.1172/JCI122258.
10
Nonalcoholic fatty liver disease: Definitions, risk factors, and workup.
Clin Liver Dis (Hoboken). 2012 Sep 25;1(4):99-103. doi: 10.1002/cld.81. eCollection 2012 Sep.
本文引用的文献
1
Histopathological characteristics of non-alcoholic fatty liver disease in children: Comparison with adult cases.
Hepatol Res. 2011 Nov;41(11):1066-74. doi: 10.1111/j.1872-034X.2011.00855.x.
2
Centrizonal arteries and microvessels in nonalcoholic steatohepatitis.
Am J Surg Pathol. 2011 Sep;35(9):1400-4. doi: 10.1097/PAS.0b013e3182254283.
3
Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.
Hepatology. 2011 Mar;53(3):810-20. doi: 10.1002/hep.24127. Epub 2011 Feb 11.
4
Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning.
J Atheroscler Thromb. 2009;16(6):893-901. doi: 10.5551/jat.2055. Epub 2009 Dec 22.
5
NASH and cryptogenic cirrhosis: a histological analysis.
Ann Hepatol. 2009 Oct-Dec;8(4):346-52.
6
Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis.
Gastroenterology. 2008 Dec;135(6):1961-1971.e2. doi: 10.1053/j.gastro.2008.08.050. Epub 2008 Sep 3.
7
Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis.
J Hepatol. 2008 May;48(5):821-8. doi: 10.1016/j.jhep.2008.01.026. Epub 2008 Feb 22.
8
Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
Gastroenterology. 2007 Jul;133(1):80-90. doi: 10.1053/j.gastro.2007.05.012. Epub 2007 May 16.
9
Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
Hepatology. 2005 Jun;41(6):1313-21. doi: 10.1002/hep.20701.
10
Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease.
Mod Pathol. 2003 Jan;16(1):49-56. doi: 10.1097/01.MP.0000042420.21088.C7.
Zotero 插件